Single User License
INR 168550
Site License
INR 337100
Corporate User License
INR 505650

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Open-Angle Glaucoma Global Clinical Trials Review, H1

Open-Angle Glaucoma Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Open-Angle Glaucoma 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Open-Angle Glaucoma 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 32

Prominent Drugs 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Novartis AG 34

Clinical Trial Overview of Novartis AG 34

Actavis plc 41

Clinical Trial Overview of Actavis plc 41

Pfizer Inc. 45

Clinical Trial Overview of Pfizer Inc. 45

Santen Pharmaceutical Co., Ltd. 48

Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 48

Aerie Pharmaceuticals, Inc. 51

Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 51

Merck & Co., Inc. 53

Clinical Trial Overview of Merck & Co., Inc. 53

Valeant Pharmaceuticals International, Inc. 54

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 54

QLT Inc. 55

Clinical Trial Overview of QLT Inc. 55

Mati Therapeutics Inc. 56

Clinical Trial Overview of Mati Therapeutics Inc. 56

Kowa Company, Ltd. 57

Clinical Trial Overview of Kowa Company, Ltd. 57

Clinical Trial Overview of Top Institutes / Government 58

Aristotle University Of Thessaloniki 58

Clinical Trial Overview of Aristotle University Of Thessaloniki 58

Medical University of Vienna 59

Clinical Trial Overview of Medical University of Vienna 59

Tehran University of Medical Sciences 60

Clinical Trial Overview of Tehran University of Medical Sciences 60

The University of Tokyo 61

Clinical Trial Overview of The University of Tokyo 61

University of Colorado 62

Clinical Trial Overview of University of Colorado 62

University of Colorado Denver 63

Clinical Trial Overview of University of Colorado Denver 63

Association for Research in Supporting System of Chronic Diseases 64

Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 64

Beijing Tongren Hospital 65

Clinical Trial Overview of Beijing Tongren Hospital 65

Federal University of Sao Paulo 66

Clinical Trial Overview of Federal University of Sao Paulo 66

Kyoto Prefectural University of Medicine 67

Clinical Trial Overview of Kyoto Prefectural University of Medicine 67

Five Key Clinical Profiles 68

Appendix 95

Abbreviations 95

Definitions 95

Research Methodology 96

Secondary Research 96

About GlobalData 97

Contact Us 97

Disclaimer 97

Source 97

List of Figures

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 96

List of Tables

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Open-Angle Glaucoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Open-Angle Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Open-Angle Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 41

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 45

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 48

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 51

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 53

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 54

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 55

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 56

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 57

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 58

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 59

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 60

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 61

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 62

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 63

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015* 64

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Tongren Hospital, 2015* 65

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 66

Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 67

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

Actavis plc

Pfizer Inc.

Santen Pharmaceutical Co., Ltd.

Aerie Pharmaceuticals, Inc.

Merck & Co., Inc.

Valeant Pharmaceuticals International, Inc.

QLT Inc.

Mati Therapeutics Inc.

Kowa Company, Ltd.

Open-Angle Glaucoma Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Open-Angle Glaucoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com